根据最终合并协议,Viewpoint的每一股已发行和流通股份将转换为获得Isoray 3.3212股的权利。Viewpoint股东将拥有Isoray完全稀释的流通股49%的股份。
$华海药业(SH600521)$ $华东医药(SZ000963...查看全文
$Isoray(ISR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-013870 Size: 5 KB 网页链接
$Isoray(ISR)$ SD Accession Number: 0001437749-20-011749 Act: 34 Size: 17 KB 网页链接
$Isoray(ISR)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001437749-20-010621 Act: 34 Size: 43 KB 网页链接
$Isoray(ISR)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001437749-20-010613 Act: 33 Size: 821 KB 网页链接
$Isoray(ISR)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-20-010494 Act: 34 Size: 3 MB 网页链接
$Isoray(ISR)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001437749-20-010431 Act: 34 Size: 222 KB 网页链接
$Isoray(ISR)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001437749-20-007211 Act: 34 Size: 251 KB 网页链接
$Isoray(ISR)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001437749-20-006661 Act: 33 Size: 334 KB 网页链接
$Isoray(ISR)$ 8-K Current report, items 1.01, 5.02, and 9.01 Accession Number: 0001437749-20-003040 Act: 34 Size: 103 KB 网页链接
$Isoray(ISR)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001437749-20-002515 Act: 33 Size: 773 KB 网页链接